SCHEMBL5056987

SCHEMBL5056987

CCCC1CCN(Cc2cc(-c3ccccc3)nc3c2ncn3Cc2ccc(OC)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.42
CTSL P07711 2/20 0.42
ACP1 P24666 2/20 0.41
MET P08581 1/20 0.40
HPGD P15428 1/20 0.40
NSD2 O96028 1/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
ADORA2A P29274 1/20 0.38
PDGFRA P16234 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
CXCR4 P61073 1/20 0.38
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
CHRM4 P08173 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5056015 0.87 CNR2 (0.45) CNR2CTSLHPGDADORA2APDGFRA
SCHEMBL1665092 0.84 CTSL (0.39) CNR2CTSLMETHPGDADORA2A
SCHEMBL5055466 0.81 HPGD (0.42) CNR2CTSLHPGDNSD2CYP11B1
SCHEMBL5053342 0.78 CNR2 (0.43) CNR2CTSLHPGDNSD2
SCHEMBL5062834 0.76 TLR7 (0.41) CNR2HPGDLMNAMAPTTSHR
SCHEMBL5062614 0.76 NR3C1 (0.43) CNR2HPGDDRD4
SCHEMBL5053350 0.71 PDE10A (0.44) CXCR4DRD4
SCHEMBL1664866 0.68 CNR2 (0.40) CNR2CTSLMETADORA2APDGFRA
SCHEMBL3705572 0.67 MEN1 (0.59) MAPT
SCHEMBL12513916 0.67 CCR3 (0.58) CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP disclosed
EP-1891042-A2 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB Pharma, S.A. (BE) 2008-02-27 EP disclosed
WO-2006128693-A2 2 -OXO-I -PYRROLIDINE DERIVATIVES/ PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed